Slough, United Kingdom

Barry Victor Lloyd Potter

This inventor holds 45 USPTO granted patents and 8 published patent applications and 6 EPO patents, primarily in Steroid Inhibitors. Top assignees: Sterix Limited, Ipsen Pharma S.a.s., Schering Aktiengesellschaft. Active years: 2002-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Barry Victor Lloyd Potter. Retrieved from https://idiyas.com/inventor/barry-victor-lloyd-potter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 45 

% Patents Active = 22.2

 

Average Co-Inventor Count = 3.3

ph-index = 6

Forward Citations = 171(Granted Patents)


Location History:

  • Avon, GB (2003 - 2006)
  • Berksire, GB (2007)
  • Bathford, GB (2005 - 2010)
  • Oxford, GB (2006 - 2010)
  • The Oxford Science Park, GB (2003 - 2011)
  • Bath, GB (2002 - 2014)
  • Slough, GB (2010 - 2014)

Company Filing History:


Years Active: 2002-2014

Loading Chart...
Loading Chart...
Areas of Expertise:
Steroid Inhibitors
Aromatase
Steroid Sulphatase
Cancer Treatment
Pharmaceutical Composition
Endocrine Tumors
Oestrogen Derivatives
Heterocyclic Compounds
Thioether Sulphamate
Phenyl-Sulfamates
17beta-HSD3
Oxime-Group
45 patents (USPTO):Explore Patents

Title: The Innovative Journey of Barry Victor Lloyd Potter

Introduction

Barry Victor Lloyd Potter is an accomplished inventor based in Slough, GB, who has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 45 patents. His innovations reflect a deep understanding of chemical compounds and their applications in medicine, paving the way for advancements in therapeutic agents.

Latest Patents

Among his latest patents, Potter has developed a compound defined by formula I, where various substituents illustrate the compound's potential versatility in pharmaceutical applications. This includes a range of functional groups such as phenyl, alkyl, and various forms of nitrogen and oxygen substituents, showcasing the compound's potential utility in medicinal chemistry.

Additionally, he has patented a solid pharmaceutical composition containing 6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate. This composition includes polymorphs of the aforementioned compound, indicating ongoing research into the optimization of drug formulation and efficacy.

Career Highlights

Throughout his career, Barry has been integral to several pharmaceutical advancements. His work with companies like Sterix Limited highlights his role in developing innovative solutions to complex medical challenges. His extensive patent portfolio underscores his commitment to driving progress in the pharmaceutical sector.

Collaborations

Barry has collaborated with notable individuals such as Michael John Reed and Atul Purohit, pooling their expertise to enhance the innovative development of pharmaceutical compounds. These collaborations reflect a synergy of talent, aiming to transform ideas into viable therapeutics that can significantly impact healthcare.

Conclusion

Barry Victor Lloyd Potter stands out as a prominent figure in the world of innovation and invention, particularly within the pharmaceutical industry. His dedication to research and development is evident through his numerous patents, collaborations, and contributions, marking him as a significant player in advancing medicinal compounds and therapeutic solutions. With each innovation, Potter continues to influence the trajectory of pharmaceutical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…